BioInvent International AB (publ) (LON: 0H22)
London flag London · Delayed Price · Currency is GBP · Price in SEK
44.54
0.00 (0.00%)
Jul 18, 2022, 5:13 PM BST

BioInvent International AB Revenue

BioInvent International AB had revenue of 12.76M SEK in the quarter ending September 30, 2024, a decrease of -52.37%. This brings the company's revenue in the last twelve months to 38.64M, down -49.68% year-over-year. In the year 2023, BioInvent International AB had annual revenue of 71.46M, down -78.09%.

Revenue (ttm)
38.64M SEK
Revenue Growth
-49.68%
P/S Ratio
n/a
Revenue / Employee
348.07K SEK
Employees
111
Market Cap
137.75M GBP

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202371.46M-254.67M-78.09%
Dec 31, 2022326.13M306.74M1,582.45%
Dec 31, 202119.38M-127.99M-86.85%
Dec 31, 2020147.37M53.63M57.21%
Dec 31, 201993.74M55.19M143.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
ConvaTec Group 1.74B
Hikma Pharmaceuticals 2.39B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings